Literature DB >> 10904238

Ambulatory blood pressure monitoring: dippers compared with non-dippers.

W B White1.   

Abstract

Epidemiologic studies have demonstrated that the peak incidence of most types of cardiovascular disease follows a circadian (24 h) pattern. Ambulatory monitoring studies have documented a reproducible 24 h rhythm for blood pressure, characterized by a period of low values during sleep, an early-morning increase in pressures, and a plateau period while the individual is awake and active. Hypertensive patients who display the typical nocturnal decrease in blood pressure are termed 'dippers', whereas patients in whom the nocturnal decrease in blood pressure is absent or blunted are termed 'non-dippers'. The circadian rhythm may be influenced by demographic, neurohormonal, and pathophysiologic factors. The non-dipper profile appears to be of prognostic significance because it is associated with increased target-organ damage and a worsened cardiovascular outcome. Chronotherapy is a new pharmacologic concept whereby medication is delivered at a time and in a concentration that varies according to physiologic need during the dosing period. Of greatest interest is the reduction in blood pressure during the early-morning blood pressure surge, as that time is associated with an increased risk for myocardial infarction and stroke. Factors that may increase the early-morning blood pressure include activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system. In the near future, the benefits of a chronotherapeutic approach to the management of hypertension should be elucidated by large-scale outcome studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10904238

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  19 in total

Review 1.  The role of the nervous system in hypertension.

Authors:  J M Wyss; S H Carlson
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment.

Authors:  S Zacharieva; M Orbetzova; A Stoynev; R Shigarminova; M Yaneva; K Kalinov; E Nachev; A Elenkova
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

3.  Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats.

Authors:  Abu Sufiun; Kazi Rafiq; Yoshihide Fujisawa; Asadur Rahman; Hirohito Mori; Daisuke Nakano; Hiroyuki Kobori; Koji Ohmori; Tsutomu Masaki; Masakazu Kohno; Akira Nishiyama
Journal:  Hypertens Res       Date:  2015-01-15       Impact factor: 3.872

4.  Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension.

Authors:  Arlene B Chapman; George Cotsonis; Vishal Parekh; Gary L Schwartz; Yan Gong; Kent R Bailey; Stephen T Turner; John G Gums; Amber L Beitelshees; Rhonda Cooper-DeHoff; Eric Boerwinkle; Julie A Johnson
Journal:  Am J Hypertens       Date:  2013-07-25       Impact factor: 2.689

5.  The day/night proteome in the murine heart.

Authors:  Peter Podobed; W Glen Pyle; Suzanne Ackloo; Faisal J Alibhai; Elena V Tsimakouridze; William F Ratcliffe; Allison Mackay; Jeremy Simpson; David C Wright; Gordon M Kirby; Martin E Young; Tami A Martino
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-15       Impact factor: 3.619

Review 6.  Cardioprotective effects of SGLT2 inhibitors are possibly associated with normalization of the circadian rhythm of blood pressure.

Authors:  Asadur Rahman; Hirofumi Hitomi; Akira Nishiyama
Journal:  Hypertens Res       Date:  2017-01-19       Impact factor: 3.872

Review 7.  The circadian clock in the kidney.

Authors:  Lisa R Stow; Michelle L Gumz
Journal:  J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 10.121

8.  The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice.

Authors:  Michelle L Gumz; Lisa R Stow; I Jeanette Lynch; Megan M Greenlee; Alicia Rudin; Brian D Cain; David R Weaver; Charles S Wingo
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

9.  Impaired reduction of nocturnal systolic blood pressure and severity of diabetic retinopathy.

Authors:  João Soares Felício; Juliana Torres Pacheco; Sandra Roberta Ferreira; Frida Plavnik; Valdir Moisés; Oswaldo Kohlmann Junior; Artur Beltrame Ribeiro; Maria Tereza Zanella
Journal:  Exp Clin Cardiol       Date:  2007

Review 10.  Valsartan: more than a decade of experience.

Authors:  Henry R Black; Jacqueline Bailey; Dion Zappe; Rita Samuel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.